News in brief
Deerland expands branded probiotic portfolio with MuniSpore ingredient
The ingredient contains Bacillus clausii CSI08, a soil-based microorganism, with reported benefits linked to its ability to positively influence microbial populations and its antioxidant effects on the immune system, said Deerland in a press release.
The strain’s safety and efficacy are reportedly supported by over 20 in vitro studies. In addition, a full genome sequencing confirmed the strain contained no plasmids, antibiotic resistant or deleterious genes, said the company.
As a spore-forming microorganism, Bacillus clausii protects itself from harsh conditions until entering an environment ideal for germination, such as the GI tract. Spore-formers remains viable under a wide temperature range and do not require refrigeration, offering formulators options for a range of products, including supplements, foods and beverages.
“The addition of MuniSpore as an option for formulation allows our customers to address the increased consumer demand for science-backed probiotic products for immune support,” said Sam Michini, Deerland’s vice president of marketing and strategy.
